Global Cannabis Extract Market Size study, by Product Type (Oil, Tinctures), by Extract Type (Full Spectrum Extracts, Cannabis Isolates), by Sources (Hemp, Marijuana), by End Use, and Regional Forecasts 2022-2032
Global Cannabis Extract Market is valued approximately at USD 4.2 billion in 2023 and is projected to expand at a robust CAGR of 20.00% over the forecast period 2024–2032. The cannabis extract industry has evolved dramatically from its niche origins into a dynamic global marketplace, shaped by shifting regulatory frameworks, rising medical adoption, and the diversification of consumer wellness preferences. With cannabis extracts now being formulated into oils, tinctures, edibles, topicals, and even pharmaceutical-grade therapeutics, their relevance across healthcare, personal care, and recreational sectors continues to deepen. Enhanced by technological advancements in extraction methods and the growing interest in non-psychoactive compounds like CBD, the market is witnessing a surge in both product innovation and acceptance across mainstream channels.
Several converging forces are propelling this market forward. The rising demand for cannabidiol-based wellness solutions is reshaping consumer behavior, particularly in managing anxiety, inflammation, chronic pain, and sleep disorders. As the stigma surrounding cannabis subsides, supported by scientific validation and legislative reform, more consumers are turning to extracts as alternatives to traditional pharmaceuticals. Full-spectrum extracts, in particular, are gaining momentum due to their ######entourage effect######—a synergistic interaction of cannabinoids and terpenes believed to enhance therapeutic outcomes. In contrast, cannabis isolates are appealing to those seeking single-compound precision in their consumption. Manufacturers are responding by tailoring formulations for specific use cases, be it clinical-grade tinctures or hemp-derived oils infused into beauty and nutrition products.
Despite this upward trajectory, the industry is navigating notable complexities. Variability in international legalization, quality control inconsistencies, and supply chain challenges continue to hinder seamless global scalability. Additionally, the high cost of supercritical CO? extraction and other advanced techniques can raise production barriers for smaller enterprises. Nevertheless, regulatory bodies in North America and Europe are actively working on standardization, and regions like Asia-Pacific are signaling openness to medical cannabis frameworks. These developments are paving the way for cross-border collaborations and investments, especially in research and pharmaceutical integrations.
The market’s diversification across sources—hemp and marijuana—adds further nuance. Hemp-derived extracts, with lower THC content, are gaining favor in countries with stricter drug policies, while marijuana-based extracts are dominating in jurisdictions with progressive recreational laws. In parallel, end-use applications are becoming increasingly segmented. The rise of cannabis-infused wellness drinks, skincare lines, and therapeutic patches points to the plant’s multidisciplinary value. Leading players are leveraging AI and blockchain to enhance product traceability, ensure purity, and strengthen consumer trust. Furthermore, advancements in nanoemulsion technologies are improving bioavailability, making extracts more effective and appealing to end users.
Regionally, North America continues to be the epicenter of growth, spearheaded by the United States and Canada’s robust consumer base, progressive policies, and flourishing dispensary infrastructure. Europe is emerging as a lucrative market as medical cannabis gains regulatory ground in countries like Germany, the UK, and the Netherlands. The Asia Pacific region is poised for exponential growth, especially in emerging economies such as Thailand and Australia, where government-led initiatives are driving cannabis research and cultivation. Meanwhile, Latin America and the Middle East & Africa are exhibiting gradual momentum, with nations exploring legalization paths and international trade opportunities in cannabis extracts.
Major market player included in this report are:
By Product Type
North America
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Several converging forces are propelling this market forward. The rising demand for cannabidiol-based wellness solutions is reshaping consumer behavior, particularly in managing anxiety, inflammation, chronic pain, and sleep disorders. As the stigma surrounding cannabis subsides, supported by scientific validation and legislative reform, more consumers are turning to extracts as alternatives to traditional pharmaceuticals. Full-spectrum extracts, in particular, are gaining momentum due to their ######entourage effect######—a synergistic interaction of cannabinoids and terpenes believed to enhance therapeutic outcomes. In contrast, cannabis isolates are appealing to those seeking single-compound precision in their consumption. Manufacturers are responding by tailoring formulations for specific use cases, be it clinical-grade tinctures or hemp-derived oils infused into beauty and nutrition products.
Despite this upward trajectory, the industry is navigating notable complexities. Variability in international legalization, quality control inconsistencies, and supply chain challenges continue to hinder seamless global scalability. Additionally, the high cost of supercritical CO? extraction and other advanced techniques can raise production barriers for smaller enterprises. Nevertheless, regulatory bodies in North America and Europe are actively working on standardization, and regions like Asia-Pacific are signaling openness to medical cannabis frameworks. These developments are paving the way for cross-border collaborations and investments, especially in research and pharmaceutical integrations.
The market’s diversification across sources—hemp and marijuana—adds further nuance. Hemp-derived extracts, with lower THC content, are gaining favor in countries with stricter drug policies, while marijuana-based extracts are dominating in jurisdictions with progressive recreational laws. In parallel, end-use applications are becoming increasingly segmented. The rise of cannabis-infused wellness drinks, skincare lines, and therapeutic patches points to the plant’s multidisciplinary value. Leading players are leveraging AI and blockchain to enhance product traceability, ensure purity, and strengthen consumer trust. Furthermore, advancements in nanoemulsion technologies are improving bioavailability, making extracts more effective and appealing to end users.
Regionally, North America continues to be the epicenter of growth, spearheaded by the United States and Canada’s robust consumer base, progressive policies, and flourishing dispensary infrastructure. Europe is emerging as a lucrative market as medical cannabis gains regulatory ground in countries like Germany, the UK, and the Netherlands. The Asia Pacific region is poised for exponential growth, especially in emerging economies such as Thailand and Australia, where government-led initiatives are driving cannabis research and cultivation. Meanwhile, Latin America and the Middle East & Africa are exhibiting gradual momentum, with nations exploring legalization paths and international trade opportunities in cannabis extracts.
Major market player included in this report are:
- Canopy Growth Corporation
- Aurora Cannabis Inc.
- GW Pharmaceuticals
- Tilray Brands Inc.
- Cronos Group Inc.
- Charlotte’s Web Holdings Inc.
- Aphria Inc.
- MedReleaf Corp.
- Curaleaf Holdings Inc.
- Green Thumb Industries
- Trulieve Cannabis Corp.
- MedMen Enterprises Inc.
- HEXO Corp.
- Organigram Holdings Inc.
- The Valens Company
By Product Type
- Oil
- Tinctures
- Full Spectrum Extracts
- Cannabis Isolates
- Hemp
- Marijuana
- Pharmaceutical
- Food & Beverage
- Cosmetics & Personal Care
- Others
North America
- U.S.
- Canada
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia Pacific
- Brazil
- Mexico
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
- Market Estimates & Forecast for 10 years from 2022 to 2032.
- Annualized revenues and regional level analysis for each market segment.
- Detailed analysis of geographical landscape with country-level analysis of major regions.
- Competitive landscape with information on major players in the market.
- Analysis of key business strategies and recommendations on future market approach.
- Analysis of competitive structure of the market.
- Demand side and supply side analysis of the market.
- Canopy Growth Corporation
- Aurora Cannabis Inc.
- GW Pharmaceuticals
- Tilray Brands Inc.
- Cronos Group Inc.
- Charlotte’s Web Holdings Inc.
- Aphria Inc.
- MedReleaf Corp.
- Curaleaf Holdings Inc.
- Green Thumb Industries
- Trulieve Cannabis Corp.
- MedMen Enterprises Inc.
- HEXO Corp.
- Organigram Holdings Inc.
- The Valens Company
CHAPTER 1. GLOBAL CANNABIS EXTRACT MARKET EXECUTIVE SUMMARY
1.1. Global Cannabis Extract Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product Type
1.3.2. By Extract Type
1.3.3. By Sources
1.3.4. By End Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
CHAPTER 2. GLOBAL CANNABIS EXTRACT MARKET DEFINITION AND RESEARCH ASSUMPTIONS
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
CHAPTER 3. GLOBAL CANNABIS EXTRACT MARKET DYNAMICS
3.1. Market Drivers
3.1.1. Rising Demand for CBD-Based Wellness Solutions
3.1.2. Legislative Reforms and Medical Adoption
3.1.3. Advances in Extraction Technologies
3.2. Market Challenges
3.2.1. Variability in International Legalization
3.2.2. Quality Control and Standardization Issues
3.2.3. High Cost of Advanced Extraction Methods
3.3. Market Opportunities
3.3.1. Cross-Border Collaborations and Research
3.3.2. AI and Blockchain for Traceability
3.3.3. Nanoemulsion and Enhanced Bioavailability
CHAPTER 4. GLOBAL CANNABIS EXTRACT MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Forces
4.1.7. Porter’s 5 Forces Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL CANNABIS EXTRACT MARKET SIZE & FORECASTS BY PRODUCT TYPE (2022–2032)
5.1. Segment Dashboard
5.2. Global Market: Oil vs. Tinctures Revenue Trend Analysis, 2022 & 2032 (USD Billion)
CHAPTER 6. GLOBAL CANNABIS EXTRACT MARKET SIZE & FORECASTS BY EXTRACT TYPE (2022–2032)
6.1. Segment Dashboard
6.2. Global Market: Full Spectrum vs. Cannabis Isolates Revenue Trend Analysis, 2022 & 2032 (USD Billion)
CHAPTER 7. GLOBAL CANNABIS EXTRACT MARKET SIZE & FORECASTS BY SOURCES (2022–2032)
7.1. Segment Dashboard
7.2. Global Market: Hemp vs. Marijuana Revenue Trend Analysis, 2022 & 2032 (USD Billion)
CHAPTER 8. GLOBAL CANNABIS EXTRACT MARKET SIZE & FORECASTS BY END USE (2022–2032)
8.1. Segment Dashboard
8.2. Global Market: Pharmaceutical; Food & Beverage; Cosmetics & Personal Care; Others Revenue Trend Analysis, 2022 & 2032 (USD Billion)
CHAPTER 9. GLOBAL CANNABIS EXTRACT MARKET SIZE & FORECASTS BY REGION (2022–2032)
9.1. North America Market
9.1.1. U.S. Market
9.1.1.1. Product Type Breakdown & Forecasts, 2022–2032
9.1.1.2. End Use Breakdown & Forecasts, 2022–2032
9.1.2. Canada Market
9.2. Europe Market
9.2.1. UK
9.2.2. Germany
9.2.3. France
9.2.4. Spain
9.2.5. Italy
9.2.6. Rest of Europe
9.3. Asia Pacific Market
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. Australia
9.3.5. South Korea
9.3.6. Rest of Asia Pacific
9.4. Latin America Market
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa Market
9.5.1. Saudi Arabia
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Key Company SWOT Analysis
10.1.1. Canopy Growth Corporation
10.1.2. Aurora Cannabis Inc.
10.1.3. GW Pharmaceuticals
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Canopy Growth Corporation
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Aurora Cannabis Inc.
10.3.3. GW Pharmaceuticals
10.3.4. Tilray Brands Inc.
10.3.5. Cronos Group Inc.
10.3.6. Charlotte’s Web Holdings Inc.
10.3.7. Aphria Inc.
10.3.8. Curaleaf Holdings Inc.
10.3.9. Green Thumb Industries
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
1.1. Global Cannabis Extract Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product Type
1.3.2. By Extract Type
1.3.3. By Sources
1.3.4. By End Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
CHAPTER 2. GLOBAL CANNABIS EXTRACT MARKET DEFINITION AND RESEARCH ASSUMPTIONS
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
CHAPTER 3. GLOBAL CANNABIS EXTRACT MARKET DYNAMICS
3.1. Market Drivers
3.1.1. Rising Demand for CBD-Based Wellness Solutions
3.1.2. Legislative Reforms and Medical Adoption
3.1.3. Advances in Extraction Technologies
3.2. Market Challenges
3.2.1. Variability in International Legalization
3.2.2. Quality Control and Standardization Issues
3.2.3. High Cost of Advanced Extraction Methods
3.3. Market Opportunities
3.3.1. Cross-Border Collaborations and Research
3.3.2. AI and Blockchain for Traceability
3.3.3. Nanoemulsion and Enhanced Bioavailability
CHAPTER 4. GLOBAL CANNABIS EXTRACT MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Forces
4.1.7. Porter’s 5 Forces Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL CANNABIS EXTRACT MARKET SIZE & FORECASTS BY PRODUCT TYPE (2022–2032)
5.1. Segment Dashboard
5.2. Global Market: Oil vs. Tinctures Revenue Trend Analysis, 2022 & 2032 (USD Billion)
CHAPTER 6. GLOBAL CANNABIS EXTRACT MARKET SIZE & FORECASTS BY EXTRACT TYPE (2022–2032)
6.1. Segment Dashboard
6.2. Global Market: Full Spectrum vs. Cannabis Isolates Revenue Trend Analysis, 2022 & 2032 (USD Billion)
CHAPTER 7. GLOBAL CANNABIS EXTRACT MARKET SIZE & FORECASTS BY SOURCES (2022–2032)
7.1. Segment Dashboard
7.2. Global Market: Hemp vs. Marijuana Revenue Trend Analysis, 2022 & 2032 (USD Billion)
CHAPTER 8. GLOBAL CANNABIS EXTRACT MARKET SIZE & FORECASTS BY END USE (2022–2032)
8.1. Segment Dashboard
8.2. Global Market: Pharmaceutical; Food & Beverage; Cosmetics & Personal Care; Others Revenue Trend Analysis, 2022 & 2032 (USD Billion)
CHAPTER 9. GLOBAL CANNABIS EXTRACT MARKET SIZE & FORECASTS BY REGION (2022–2032)
9.1. North America Market
9.1.1. U.S. Market
9.1.1.1. Product Type Breakdown & Forecasts, 2022–2032
9.1.1.2. End Use Breakdown & Forecasts, 2022–2032
9.1.2. Canada Market
9.2. Europe Market
9.2.1. UK
9.2.2. Germany
9.2.3. France
9.2.4. Spain
9.2.5. Italy
9.2.6. Rest of Europe
9.3. Asia Pacific Market
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. Australia
9.3.5. South Korea
9.3.6. Rest of Asia Pacific
9.4. Latin America Market
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa Market
9.5.1. Saudi Arabia
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Key Company SWOT Analysis
10.1.1. Canopy Growth Corporation
10.1.2. Aurora Cannabis Inc.
10.1.3. GW Pharmaceuticals
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Canopy Growth Corporation
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Aurora Cannabis Inc.
10.3.3. GW Pharmaceuticals
10.3.4. Tilray Brands Inc.
10.3.5. Cronos Group Inc.
10.3.6. Charlotte’s Web Holdings Inc.
10.3.7. Aphria Inc.
10.3.8. Curaleaf Holdings Inc.
10.3.9. Green Thumb Industries
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
LIST OF TABLES
TABLE 1. Global Cannabis Extract market, report scope
TABLE 2. Global cannabis extract market estimates & forecasts by Region 2022–2032 (USD Billion)
TABLE 3. Global market estimates & forecasts by Product Type 2022–2032 (USD Billion)
TABLE 4. Global market estimates & forecasts by Extract Type 2022–2032 (USD Billion)
TABLE 5. Global market estimates & forecasts by Sources 2022–2032 (USD Billion)
TABLE 6. Global market estimates & forecasts by End Use 2022–2032 (USD Billion)
TABLE 7. North America market estimates & forecasts, 2022–2032 (USD Billion)
TABLE 8. U.S. market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 9. Canada market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 10. Europe market estimates & forecasts, 2022–2032 (USD Billion)
TABLE 11. UK market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 12. Germany market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 13. Asia Pacific market estimates & forecasts, 2022–2032 (USD Billion)
TABLE 14. China market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 15. India market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 16. Latin America market estimates & forecasts, 2022–2032 (USD Billion)
TABLE 17. Brazil market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 18. Middle East & Africa market estimates & forecasts, 2022–2032 (USD Billion)
TABLE 19. Saudi Arabia market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 20. South Africa market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 1. Global Cannabis Extract market, report scope
TABLE 2. Global cannabis extract market estimates & forecasts by Region 2022–2032 (USD Billion)
TABLE 3. Global market estimates & forecasts by Product Type 2022–2032 (USD Billion)
TABLE 4. Global market estimates & forecasts by Extract Type 2022–2032 (USD Billion)
TABLE 5. Global market estimates & forecasts by Sources 2022–2032 (USD Billion)
TABLE 6. Global market estimates & forecasts by End Use 2022–2032 (USD Billion)
TABLE 7. North America market estimates & forecasts, 2022–2032 (USD Billion)
TABLE 8. U.S. market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 9. Canada market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 10. Europe market estimates & forecasts, 2022–2032 (USD Billion)
TABLE 11. UK market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 12. Germany market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 13. Asia Pacific market estimates & forecasts, 2022–2032 (USD Billion)
TABLE 14. China market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 15. India market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 16. Latin America market estimates & forecasts, 2022–2032 (USD Billion)
TABLE 17. Brazil market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 18. Middle East & Africa market estimates & forecasts, 2022–2032 (USD Billion)
TABLE 19. Saudi Arabia market estimates & forecasts by segment, 2022–2032 (USD Billion)
TABLE 20. South Africa market estimates & forecasts by segment, 2022–2032 (USD Billion)
LIST OF FIGURES
FIG 1. Global Cannabis Extract market, research methodology
FIG 2. Global market, estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global market, key trends 2023
FIG 5. Global market, growth prospects 2022–2032
FIG 6. Global market, Porter’s 5 Forces model
FIG 7. Global market, PESTEL analysis
FIG 8. Global market, value chain analysis
FIG 9. Market by Product Type, 2022 & 2032 (USD Billion)
FIG 10. Market by Extract Type, 2022 & 2032 (USD Billion)
FIG 11. Market by Sources, 2022 & 2032 (USD Billion)
FIG 12. Market by End Use, 2022 & 2032 (USD Billion)
FIG 13. Global market, regional snapshot 2022 & 2032
FIG 14. North America market, 2022 & 2032 (USD Billion)
FIG 15. Europe market, 2022 & 2032 (USD Billion)
FIG 16. Asia Pacific market, 2022 & 2032 (USD Billion)
FIG 17. Latin America market, 2022 & 2032 (USD Billion)
FIG 18. Middle East & Africa market, 2022 & 2032 (USD Billion)
FIG 19. Global market, company market share analysis (2023)
FIG 20. Global market, challenges and opportunities framework
FIG 1. Global Cannabis Extract market, research methodology
FIG 2. Global market, estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global market, key trends 2023
FIG 5. Global market, growth prospects 2022–2032
FIG 6. Global market, Porter’s 5 Forces model
FIG 7. Global market, PESTEL analysis
FIG 8. Global market, value chain analysis
FIG 9. Market by Product Type, 2022 & 2032 (USD Billion)
FIG 10. Market by Extract Type, 2022 & 2032 (USD Billion)
FIG 11. Market by Sources, 2022 & 2032 (USD Billion)
FIG 12. Market by End Use, 2022 & 2032 (USD Billion)
FIG 13. Global market, regional snapshot 2022 & 2032
FIG 14. North America market, 2022 & 2032 (USD Billion)
FIG 15. Europe market, 2022 & 2032 (USD Billion)
FIG 16. Asia Pacific market, 2022 & 2032 (USD Billion)
FIG 17. Latin America market, 2022 & 2032 (USD Billion)
FIG 18. Middle East & Africa market, 2022 & 2032 (USD Billion)
FIG 19. Global market, company market share analysis (2023)
FIG 20. Global market, challenges and opportunities framework
